Showing results (291-300 of 384) with videos related to
Sort By:
Pageof 39
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2022
Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO GuidelineEmrullah Yilmaz, Nofisat Ismaila, Julie E Bauman, et al.Cancer|September 21, 2016
A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neckAntonio Jimeno, Marshall R Posner, Lori J Wirth, et al.The Journal of Clinical Investigation|May 14, 2019
Inositol-triphosphate 3-kinase B confers cisplatin resistance by regulating NOX4-dependent redox balanceChaoyun Pan, Lingtao Jin, Xu Wang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 28, 2023
Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck CancerJulie E Bauman, Nabil F Saba, Denise Roe, et al.European Journal of Cancer (Oxford, England : 1990)|March 30, 2025
Artificial intelligence-based virtual staining platform for identifying tumor-associated macrophages from hematoxylin and eosin-stained imagesArpit Aggarwal, Mayukhmala Jana, Amritpal Singh, et al.The Laryngoscope|August 9, 2025
DNA Immunotherapy (INO-3107) Results in Long-Term Surgery Reduction in RRPMilan R Amin, Peter C Belafsky, Simon R Best, et al.Cancer|May 5, 2016
Treatment allocation in patients with early-stage esophageal adenocarcinoma: Prevalence and predictors of lymph node involvementAnthony M Gamboa, Sungjin Kim, Seth D Force, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2019
Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab UseRobert L Ferris, Lisa Licitra, Jerome Fayette, et al.Critical Reviews in Oncology/Hematology|April 25, 2019
Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma: A review of the literaturePaolo Bossi, Salvatore Alfieri, Primoz Strojan, et al.Cancers|January 28, 2026
Quantitative Imaging Advances in HPV-Positive Oropharyngeal CarcinomaDermot Farrell, Houda Bahig, Richard Khor, et al.Pageof 39